Case Studies

12 of 22

Putting a therapeutics startup in front of the perfect audiences

Pinkston Case Study

The Client engaged Pinkston to help shape and share its story with potential investors and non-dilutive funding partners through earned media outreach.

Pinkston began by conducting an extensive discovery and messaging process to help distill the Client's story and package it into compelling narratives that would resonate with different audiences. This included a biotechnology and clinical trials angle; a "founder's story" angle; and a narrative surrounding potential defense applications for the technology.

Through a challenging news cycle that was largely focused on Covid, Pinkston secured coverage in numerous trade publications, including Orthopedics This Week, MedTech Insight, MedGadget, The Scientist, Chemical and Engineering News, BioProcess Insider, Genetic Engineering and Biotechnology News, and The Medicine Maker. We also secured coverage in mainstream and veterans publications including,, Washington Times, BostInno and more.

The pieces attracted positive attention from investors and industry partners, and helped close a successful seed funding round that is fueling the company through the next stage of its business plan.

All Case Studies

Christian and his team impressed me with their ability to balance grace and tenacity in guiding us through a challenging time. So I didn’t hesitate to call on them again for advice and PR management. Their efforts continue to strengthen UM Holdings companies.
John aglialoro

John Aglialoro
Chairman & CEO
UM Holdings Ltd.